| Dexamethasone in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 384 (8), 693-704, 2021 | 2863 | 2021 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10285), 1637-1645, 2021 | 1605 | 2021 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1482 | 2020 |
| Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ... The Lancet 396 (10259), 1345-1352, 2020 | 818 | 2020 |
| Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric … T Ramcharan, O Nolan, CY Lai, N Prabhu, R Krishnamurthy, AG Richter, ... Pediatric cardiology 41, 1391-1401, 2020 | 426 | 2020 |
| Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RC Group The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021 | 379* | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 249 | 2022 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 214 | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 202 | 2022 |
| Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 397 (10289), 2049-2059, 2021 | 164* | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 79 | 2022 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 24 | 2023 |
| Hallmarks of the tumour microenvironment of gliomas and its interaction with emerging immunotherapy modalities CA Linares, A Varghese, A Ghose, SD Shinde, S Adeleke, E Sanchez, ... International Journal of Molecular Sciences 24 (17), 13215, 2023 | 7 | 2023 |
| Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised … SN Faust, R Haynes, CE Jones, N Staplin, E Whittaker, T Jaki, E Juszczak, ... The Lancet Child & Adolescent Health 8 (3), 190-200, 2024 | 6 | 2024 |
| Lemierre’s syndrome involving milleri group streptococci: further insight into age and aetiology CA Linares, F Ryan, I Hajat, S Glass BMJ Case Rep 13 (11), e238062, 2020 | 4 | 2020 |
| Glioblastoma and radiotherapy: A multicenter AI study for Survival Predictions from MRI (GRASP study) A Chelliah, DA Wood, LS Canas, H Shuaib, S Currie, K Fatania, R Frood, ... Neuro-oncology 26 (6), 1138-1151, 2024 | 3 | 2024 |
| Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Data Monitoring Committee of the RECOVERY ... Nature Communications 15 (1), 924, 2024 | 3 | 2024 |
| Overcoming challenges of translating deep-learning models for glioblastoma: the ZGBM consortium H Shuaib, GJ Barker, P Sasieni, E De Vita, A Chelliah, R Andrei, ... The British journal of radiology 96 (1141), 20220206, 2023 | 2 | 2023 |
| Paediatric anatomical models in radiotherapy applications V Apte, A Ghose, CA Linares, S Adeleke, V Papadopoulos, E Rassy, ... Clinical Oncology 36 (9), 562-575, 2024 | | 2024 |
| P13. 10. A PREDICTING SURVIVAL OF GLIOBLASTOMAAFTER RADIOTHERAPY USING DEEP LEARNING AND NEUROIMAGING IN A MULTI-CENTRE COHORT A Chelliah, DA Wood, LS Canas, H Shuaib, C Linares, A Bassiouny, ... Neuro-Oncology 25 (Supplement_2), ii103-ii103, 2023 | | 2023 |
